Member Info for popes11

Held these a few years ago and sold out. Hoping for upwards of 3p at least again this time.

Don't drink anymore however if I did it would be Redleg ginger beer and lime.

The money shot is many multiples of current share price if we end up with a product. This action is merely green shoots.

Presentation happening tomorrow so potentially a few new buyers in the coming days.

Any serious spike will come when there is a real possibility of a product to sell. The rise over past month is nothing and todays price should hopefully look like a real bargain. Further results from trials will tells us where this is going next.

An attempt to clear out the cowboys when professional's are about to enter the market can only be good.

Paying up to $50,000 per treatment for unproven treatment from dodgy clinics according to that article.

What will the price be for established proven treatment? 100,000 in America alone with eye conditions that will benefit.

That adds up to a lot of people who can benefit and hopefully can afford to pay.

a long way to go until 600p which is probably the average of long term holders of RENE stock. A bit of momentum and we may just see that. Notice somebody punted 15 shares. I hope they enjoy their fish and chips.

https://www.proactiveinvestors.co.uk/companies/news/217933/reneuron-provides-further-encouraging-update-for-potential-sight-saving-treatment-217933.html

We remain greatly encouraged by the continued positive efficacy we are seeing," said chief executive Olav Hellebø

eye chart

The latest group to be treated with human retinal progenitor cells comprises patients who have a greater baseline level of visual acuity (clarity of vision) than those taking part in the clinical assessment thus far


ReNeuron Group PLC (LON:RENE) shares leapt higher on Thursday after the group said its cell therapy for blindness-causing disease retinitis pigmentosa is proving efficacious in the first group of phase II patients receiving the treatment.

This follows from February’s update from which it emerged that the first three people taking part in the phase I/II study were able to read an additional three lines of a standard eye chart.

The latest group to be treated with human retinal progenitor cells (hRPCs) comprises patients who have a greater baseline level of visual acuity (clarity of vision) than those taking part in the clinical assessment thus far.

Further data from the trial will be shared at the Sixth Annual Retinal Cell and Gene Therapy Innovation Summit, in Vancouver, Canada, later this month.

"We remain greatly encouraged by the continued positive efficacy we are seeing in the ongoing phase I/II study with our hRPC cell therapy candidate for retinitis pigmentosa,” said ReNeuron chief executive Olav Hellebø.

“We look forward to providing a further update on progress with the study at the time of the Innovation Summit in Vancouver later this month."

In mid-morning trading, ReNeuron shares soared 17% higher to 142p

Looks like retinal results is driving this. That's no bad thing as it's not speculation driving the price forward. 150p will look very cheap if these trials keep going well.

Looks like small PI selling up and chunky buys coming in. I'm not selling up just as things look very positive after a decade of waiting.

Hope you enjoy the new Stadium.

Is good news here in the next 4-6 months. It will mean that the trials are going well as per the presentation on 21st March. Not so bothered by short term fluctuations here now as there is a potentially game changing RNS to anticipate.

https://youtu.be/DhIz6Jmz8ZU

watch from 4.10 that's the money shot. Improved clearly made in treated eye. Average 16 letter gain in very short period of time.

Share chart is looking like people with deep pockets attended that investor day on march 21st and liked what they saw .Specifically the results from the Hrpc appear to be whats driving the recent rise. This summer should be interesting.

Alive and kicking great. Long term holders got a way to go before any celebrations I would say.
Still nice to see a bit of action. Its only been 11 years or so.

he may just not be alive anymore. I recall a few years ago he did not keep well. Hopefully just on holiday.

I have written off my 10 year old investment. Fresh holding in isa is my focus. Having held so long I would love to see one of their products on the market. I know a kid who would benefit from the RP treatment. Can't be nice knowing your child will eventually go blind. That's the reality of this share and what can be achieved.

" a firm and binding offer for the company which includes satisfactory arrangements to refinance the group debt that becomes due and payable on a change of control, and provides the group with sufficient working capital; or"

So MA the door is still open. All you have to do is take ownership of the debt and put up the money for the company to continue. Well of course the board would be open to that deal. IMHO MA will cut his losses and try and pick it up on the cheap later.

Before any long term holders sell up. Most need multiples of todays price to break even let alone sell up.

No real positive news for a while now to stop these drifting further south. Been in and out of these over the years. The OBC is a bonus if when they level out a bit.